Dr. Joseph M. Anderson
Claim this profileBeaumont Hospital - Dearborn
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
3 reported clinical trials
7 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
2Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Joseph M. Anderson is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Joseph M. Anderson
Clinical Trial Related9 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Joseph M. Anderson has experience with
- Biospecimen Collection
- Crizotinib
- Pembrolizumab
- Pemetrexed Disodium
- Carboplatin
- Gemcitabine Hydrochloride
Breakdown of trials Joseph M. Anderson has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph M. Anderson specialize in?
Joseph M. Anderson focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Joseph M. Anderson currently recruiting for clinical trials?
Yes, Joseph M. Anderson is currently recruiting for 3 clinical trials in Dearborn Michigan. If you're interested in participating, you should apply.
Are there any treatments that Joseph M. Anderson has studied deeply?
Yes, Joseph M. Anderson has studied treatments such as Biospecimen Collection, Crizotinib, Pembrolizumab.
What is the best way to schedule an appointment with Joseph M. Anderson?
Apply for one of the trials that Joseph M. Anderson is conducting.
What is the office address of Joseph M. Anderson?
The office of Joseph M. Anderson is located at: Beaumont Hospital - Dearborn, Dearborn, Michigan 48124 United States. This is the address for their practice at the Beaumont Hospital - Dearborn.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.